1. Home
  2. KRMD vs CRBU Comparison

KRMD vs CRBU Comparison

Compare KRMD & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

N/A

Current Price

$4.62

Market Cap

221.0M

Sector

Health Care

ML Signal

N/A

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

N/A

Current Price

$1.99

Market Cap

203.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KRMD
CRBU
Founded
1980
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
221.0M
203.9M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
KRMD
CRBU
Price
$4.62
$1.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$6.00
$10.00
AVG Volume (30 Days)
161.1K
1.2M
Earning Date
04-14-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
56.67
3.64
EPS
0.05
N/A
Revenue
$33,646,463.00
N/A
Revenue This Year
$24.39
N/A
Revenue Next Year
$18.14
$10.48
P/E Ratio
$91.10
N/A
Revenue Growth
17.98
N/A
52 Week Low
$1.87
$0.66
52 Week High
$6.61
$3.53

Technical Indicators

Market Signals
Indicator
KRMD
CRBU
Relative Strength Index (RSI) 40.18 59.91
Support Level $3.80 $1.71
Resistance Level $5.12 $2.11
Average True Range (ATR) 0.24 0.16
MACD 0.01 0.00
Stochastic Oscillator 34.21 66.67

Price Performance

Historical Comparison
KRMD
CRBU

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: